These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS. Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660 [Abstract] [Full Text] [Related]
5. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling? Diener HC. Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062 [Abstract] [Full Text] [Related]
6. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view. Gebel JM. J Am Coll Cardiol; 2005 Sep 06; 46(5):752-5. PubMed ID: 16139120 [Abstract] [Full Text] [Related]
7. Combination antiplatelet agents for secondary prevention of ischemic stroke. Vande Griend JP, Saseen JJ. Pharmacotherapy; 2008 Oct 06; 28(10):1233-42. PubMed ID: 18823219 [Abstract] [Full Text] [Related]
12. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. Biller J. J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153 [Abstract] [Full Text] [Related]
16. Update on aspirin in the treatment and prevention of cardiovascular disease. Hennekens CH. Am J Manag Care; 2002 Dec 15; 8(22 Suppl):S691-700. PubMed ID: 12512736 [Abstract] [Full Text] [Related]
19. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review. Simmons BB, Yeo A, Fung K, American Heart Association, American Stroke Association. Postgrad Med; 2010 Mar 15; 122(2):49-53. PubMed ID: 20203455 [Abstract] [Full Text] [Related]